No Prescription |
 |
 | ||
|
STUGERON Generic Cinnarizine |
|
| ||
No Prescription » Prescription Drugs 15 » STUGERON Generic Cinnarizine Stugeron tablets contain the active ingredient cinnarizine which is a type of medicine called an antihistamine. (NB. Cinnarizine is also available without a brand name ie as the generic medicine.) Cinnarizine is used to control travel sickness and the symptoms of inner ear disorders such as Meniere's disease.Vomiting is controlled by an area of the brain called the vomiting centre. The vomiting centre is responsible for causing feelings of sickness (nausea) and for the vomiting reflex. It is activated when it receives nerve messages from the vestibular apparatus in the middle ear. The vestibular apparatus provides continual feedback to the brain about our body position. When something disturbs the vestibular apparatus such movement of the head when travelling by boat or car nerve signals are sent from the vestibular apparatus to the vomiting centre. This can cause sensations such as nausea dizziness or spinning sensations (vertigo) and the reflex of vomiting.Cinnarizine works by blocking histamine and muscarinic receptors in the vomiting centre in the brain. This prevents the vomiting centre from receiving nerve messages from the vestibular apparatus. In turn this prevents disturbances in the middle ear from activating the vomiting centre and causing nausea vertigo and vomiting. What is it used for?Preventing and treating motion sicknessRelieving nausea vomiting attacks of dizziness or spinning sensations (vertigo) and sensations of ringing or other noise in the ears (tinnitus) associated with Meniere's disease and other middle ear disorders. Buy STUGERON Generic Cinnarizine and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About STUGERON Generic Cinnarizine: Product Type: Prescription Drugs 15 STUGERON ( Generic Cinnarizine ) STUGERON (Generic Cinnarizine) Generic Cinnarizine 25 mg tabs Generic Cinnarizine STUGERON
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
